The Ensign Group, Inc. (NASDAQ:ENSG – Get Free Report) Director John Agwunobi sold 392 shares of the firm’s stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the transaction, the director directly owned 9,503 shares of the company’s stock, valued at $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
The Ensign Group Stock Down 0.7%
ENSG stock opened at $181.89 on Thursday. The firm’s fifty day simple moving average is $165.54 and its 200-day simple moving average is $183.97. The company has a market capitalization of $10.60 billion, a P/E ratio of 28.51, a price-to-earnings-growth ratio of 1.79 and a beta of 0.69. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.56. The Ensign Group, Inc. has a 12 month low of $141.58 and a 12 month high of $218.00.
The Ensign Group (NASDAQ:ENSG – Get Free Report) last issued its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter last year, the company posted $1.59 earnings per share. The firm’s revenue was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. As a group, equities research analysts forecast that The Ensign Group, Inc. will post 6.82 earnings per share for the current year.
The Ensign Group Announces Dividend
Analysts Set New Price Targets
A number of analysts have recently commented on the company. Zacks Research downgraded The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Truist Financial reduced their price target on The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research report on Tuesday, July 14th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $215.00.
View Our Latest Stock Analysis on ENSG
Institutional Investors Weigh In On The Ensign Group
Hedge funds have recently modified their holdings of the company. Parkside Financial Bank & Trust increased its stake in shares of The Ensign Group by 2.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,000 shares of the company’s stock valued at $348,000 after purchasing an additional 57 shares in the last quarter. Csenge Advisory Group boosted its position in The Ensign Group by 3.7% during the fourth quarter. Csenge Advisory Group now owns 1,642 shares of the company’s stock worth $286,000 after purchasing an additional 58 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in The Ensign Group by 0.4% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,451 shares of the company’s stock worth $2,912,000 after purchasing an additional 58 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in The Ensign Group by 55.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock valued at $30,000 after purchasing an additional 61 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in The Ensign Group by 2.9% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 2,189 shares of the company’s stock valued at $381,000 after purchasing an additional 62 shares during the period. 96.12% of the stock is owned by hedge funds and other institutional investors.
The Ensign Group News Roundup
Here are the key news stories impacting The Ensign Group this week:
- Positive Sentiment: Q2 earnings beat expectations: Ensign reported adjusted EPS of $1.92, ahead of the $1.80 consensus estimate and up from $1.59 a year earlier. Revenue reached approximately $1.44 billion, increasing about 17% year over year. The Ensign Group 2026 Q2 Results Earnings Call Presentation
- Positive Sentiment: Raised full-year outlook: Management set 2026 adjusted EPS guidance at $7.75–$7.85, supporting expectations for continued earnings growth. Operating indicators, including occupancy, skilled-mix revenue and facility expansion, also remained favorable.
- Positive Sentiment: Analyst support: Recent coverage described Ensign as a bullish healthcare name, with reported analyst targets generally above recent trading levels. RBC maintained an outperform rating and a $228 target, while the broader consensus remains “Moderate Buy.” Analysts Are Bullish on The Ensign Group
- Neutral Sentiment: Planned insider sale: Director John Agwunobi sold 392 shares for approximately $67,056, reducing his holdings by 3.96%. Because the transaction occurred under a pre-arranged Rule 10b5-1 plan, it is a limited bearish signal. John Agwunobi Sells Ensign Shares
- Negative Sentiment: Legal and reputational overhang: Kaplan Fox, Bleichmar Fonti & Auld and Rosen Law Firm announced investigations into potential securities-law violations tied to allegations in a Hunterbrook short report concerning staffing, care quality, regulatory issues and disclosures. The claims remain unproven, but the investigations could increase litigation, regulatory and reputational risks. Kaplan Fox Ensign Investigation
About The Ensign Group
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
Read More
- Five stocks we like better than The Ensign Group
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.
